10-QPeriod: Q3 FY2025

UNITEDHEALTH GROUP INC Quarterly Report for Q3 Ended Sep 30, 2025

Filed October 28, 2025For Securities:UNH

Summary

UnitedHealth Group (UNH) reported its third-quarter 2025 results, showcasing robust revenue growth of 12% year-over-year to $113.2 billion, driven by strong performance across its UnitedHealthcare and Optum segments. Despite revenue expansion, the company experienced a significant decrease in earnings from operations, which fell 50% to $4.3 billion. This decline is attributed to a substantial increase in medical costs, up 21% to $80 billion, driven by higher care patterns, increased unit costs, and the impacts of the Inflation Reduction Act on Medicare Part D plans. The medical care ratio (MCR) consequently rose to 89.9% from 85.2% in the prior year. While the company continues to expand its reach, serving 795,000 more people primarily through Medicare Advantage, the pressure on medical costs and regulatory factors like Medicare Advantage funding reductions are impacting profitability. UnitedHealthcare's earnings from operations declined 57%, while Optum Health saw an 88% decrease, highlighting the challenges in managing health care costs within these segments. Conversely, Optum Insight and Optum Rx demonstrated resilience, with Optum Insight's earnings growing 46% and Optum Rx remaining stable, underscoring the diverse performance across UNH's business units. Investors should closely monitor the company's ability to manage medical cost trends and navigate the evolving regulatory landscape.

Financial Highlights

55 data points
Beta

Revenue

$113.16B

88.9% Gross Margin

Net Income

$2.35B

2.1% Net Margin

EPS (Diluted)

$2.59

Total Assets

$315.27B

Cash & Equivalents

$27.21B

Free Cash Flow

$5.05B

Financial Statements
Beta
Revenue$113.16B
Cost of Revenue$12.57B
Gross Profit$100.59B
SG&A Expenses$15.22B
Operating Expenses$108.85B
Operating Income$4.32B
Interest Expense$1.00B
Net Income$2.35B
EPS (Basic)$2.59
EPS (Diluted)$2.59
Shares Outstanding (Basic)906.00M
Shares Outstanding (Diluted)908.00M

Key Highlights

  • 1Consolidated revenues grew 12% to $113.2 billion, driven by UnitedHealthcare (up 16%) and Optum (up 8%).
  • 2Earnings from operations decreased significantly by 50% to $4.3 billion, impacted by elevated medical costs and regulatory factors.
  • 3Medical costs surged 21% to $80 billion, leading to an increase in the Medical Care Ratio (MCR) to 89.9% from 85.2% year-over-year.
  • 4UnitedHealthcare served 795,000 more people, primarily due to growth in Medicare Advantage.
  • 5Optum Health experienced an 88% decrease in earnings from operations, largely due to Medicare Advantage funding reductions and rising medical costs.
  • 6Optum Insight saw a substantial 46% increase in earnings from operations, indicating strong performance in this segment.
  • 7Cash flows from operations for the nine months ended September 30, 2025, were $18.6 billion, although lower than the prior year's $21.8 billion.

Frequently Asked Questions

The primary driver for the substantial decrease in earnings from operations is the significant increase in medical costs, which rose 21% year-over-year. This rise is attributed to higher care patterns, increased unit costs, and the impact of the Inflation Reduction Act on Medicare Part D plans, leading to a higher Medical Care Ratio (MCR).

UnitedHealthcare revenues grew 16%, supported by an increase of 795,000 served members, largely driven by Medicare Advantage growth. However, earnings from operations decreased by 57%. This decline is primarily due to Medicare Advantage funding reductions, elevated medical cost trends, market morbidity changes affecting individual exchange offerings, and other write-offs and settlements.

Optum Health's earnings from operations experienced an 88% decrease. This is driven by Medicare Advantage funding reductions, the profile of newly added patients in value-based care arrangements, elevated medical cost trends, and business portfolio refinement. The company is facing pressure from insufficient funding rates in Medicaid and Medicare Advantage, impacting margins.

UnitedHealth Group maintains substantial liquidity, with cash, cash equivalents, available-for-sale debt securities, and marketable equity securities totaling $76.3 billion as of September 30, 2025. Cash flow from operations for the nine months was $18.6 billion. The company continues to fund its operations, pay dividends, and repurchase shares, indicating a belief in sufficient capital resources for future needs. However, the company notes that increased MCR is impacting the amount of dividends its regulated subsidiaries can pay to parent companies.